Approval · Notice of Compliance 1574 · 1999
PRANDASE: Notice of Compliance 1574
Issued August 18, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1574
- Date
- August 18, 1999
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- For use in combination with metformin or insulin in the treatment of patients with type 2 diabetes mellitus
- Therapeutic class
- Oral antidiabetic agent, alpha-glucosidase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRANDASE | Not yet assigned | — |